On a sequential basis, we expect growth in the second quarter and stronger growth in the third quarter.
With our recent occupancy growth and net MIMO results, we believe that we are at a positive inflection point.
Adjusted EBITDA for the first quarter 2021 was $35 million compared to $185 million for the prior year quarter, of which $100 million was from the one-time management termination fee related to the Healthpeak transaction, I just mentioned.
